glucose, (beta-d)-isomer and lobeglitazone
glucose, (beta-d)-isomer has been researched along with lobeglitazone in 3 studies
Research
Studies (3)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Jang, K; Jeon, JY; Kim, MG; Moon, SJ | 1 |
Hwang, JG; Kim, YK; Park, MK | 1 |
Ahn, SH; Cho, Y; Choi, YJ; Hong, S; Kim, SH; Lee, E; Lee, YH; Seo, DH; Seo, S; Suh, YJ | 1 |
Trials
2 trial(s) available for glucose, (beta-d)-isomer and lobeglitazone
Article | Year |
---|---|
Evaluation of the Pharmacokinetic Interaction Between Lobeglitazone and Dapagliflozin at Steady State.
Topics: Adult; Benzhydryl Compounds; Cross-Over Studies; Drug Interactions; Fasting; Glucosides; Healthy Volunteers; Humans; Hypoglycemic Agents; Male; Pyrimidines; Therapeutic Equivalency; Thiazolidinediones; Young Adult | 2020 |
No Relevant Pharmacokinetic Drug-Drug Interaction Between the Sodium-Glucose Co-Transporter-2 Inhibitor Empagliflozin and Lobeglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, in Healthy Subjects.
Topics: Administration, Oral; Adult; Benzhydryl Compounds; Drug Interactions; Drug Tolerance; Glucosides; Healthy Volunteers; Humans; Male; Middle Aged; PPAR gamma; Pyrimidines; Sodium-Glucose Transporter 2 Inhibitors; Thiazolidinediones; Young Adult | 2021 |
Other Studies
1 other study(ies) available for glucose, (beta-d)-isomer and lobeglitazone
Article | Year |
---|---|
Effect of Dapagliflozin in Combination with Lobeglitazone and Metformin in Korean Patients with Type 2 Diabetes in Real-World Clinical Practice.
Topics: Benzhydryl Compounds; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Metformin; Pyrimidines; Republic of Korea; Thiazolidinediones; Treatment Outcome | 2022 |